Dimensioni, segmenti e analisi del mercato dei farmaci antielmintici per animali domestici entro il 2025-2031
Pet Anthelmintic Drugs Market Report Analysis
Pet Anthelmintic Drugs Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX million -
Market Size 2031
US$ XX Million

Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Novartis AG
- Cipla Inc.
- Sun Pharmaceutical Industries Ltd
- Amneal Pharmaceuticals LLC. (Impax Laboratories, Inc.)
- Zoetis, Inc.
- GlaxoSmithKline plc
- Bayer AG
- Merck & Co., Inc. (Intervet Inc.)
- Boehringer Ingelheim International GmbH
Regional Overview

- Nord America
- Europa
- Asia-Pacifico
- America centrale e meridionale
- Medio Oriente e Africa
Market Segmentation

- Ascaris Lumbricoides [ascaridi]
- Trichuris Trichiura [tricocefali]
- Enterobius Vermicularis [ossiuri]
- Ancylostoma Duodenale [anchilostomi]
- altri

- farmacie veterinarie
- ospedali e cliniche veterinarie

- America del Nord
- Europa
- Asia-Pacifico
- America centrale e meridionale